Search Results - Rudolf A. de Boer

Refine Results
  1. 1
    Management of cardiac fibrosis is the largest unmet medical need in heart failure

    Management of cardiac fibrosis is the largest unmet medical need in heart failure by Javier Dı́ez, Rudolf A. de Boer

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Common risk factors for heart failure and cancer

    Common risk factors for heart failure and cancer by Wouter C. Meijers, Rudolf A. de Boer

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Sodium–glucose cotransporter 2 inhibition: cardioprotection by treating diabetes—a translational viewpoint explaining its potential salutary effects

    Sodium–glucose cotransporter 2 inhibition: cardioprotection by treating diabetes—a translational viewpoint explaining its potential salutary effects by Anne E. de Leeuw, Rudolf A. de Boer

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

    Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer by Anja Karlstaedt, Javid J. Moslehi, Rudolf A. de Boer

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Galectin-3 in Cardiac Remodeling and Heart Failure

    Galectin-3 in Cardiac Remodeling and Heart Failure by Rudolf A. de Boer, Lili Yu, Dirk J. van Veldhuisen

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    The fibrosis-cell death axis in heart failure

    The fibrosis-cell death axis in heart failure by Arnold Piek, Rudolf A. de Boer, Herman H.W. Silljé

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease

    Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease by Joseph Pierre Aboumsallem, Javid J. Moslehi, Rudolf A. de Boer

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Emerging role of liver X receptors in cardiac pathophysiology and heart failure

    Emerging role of liver X receptors in cardiac pathophysiology and heart failure by Megan V. Cannon, Wiek H. van Gilst, Rudolf A. de Boer

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Galectin-3 in Heart Failure

    Galectin-3 in Heart Failure by Carolin Gehlken, Navin Suthahar, Wouter C. Meijers, Rudolf A. de Boer

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Current understanding of fibrosis in genetic cardiomyopathies

    Current understanding of fibrosis in genetic cardiomyopathies by Tim R. Eijgenraam, Herman H.W. Silljé, Rudolf A. de Boer

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    State of the Art: Newer biomarkers in heart failure

    State of the Art: Newer biomarkers in heart failure by Rudolf A. de Boer, Lori B. Daniels, Alan S. Maisel, James L. Januzzi

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Biomarkers in heart failure with preserved ejection fraction

    Biomarkers in heart failure with preserved ejection fraction by Wouter C. Meijers, A. Rogier van der Velde, Rudolf A. de Boer

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Novel heart failure biomarkers: why do we fail to exploit their potential?

    Novel heart failure biomarkers: why do we fail to exploit their potential? by Arnold Piek, Weijie Du, Rudolf A. de Boer, Herman H.W. Silljé

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

    Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies by Sanne de Wit, Claire Glen, Rudolf A. de Boer, Ninian N. Lang

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities

    From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities by Navin Suthahar, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Telemedicine in heart failure—more than nice to have?

    Telemedicine in heart failure—more than nice to have? by Casper Eurlings, Josiane Boyne, Rudolf A. de Boer, Hans‐Peter Brunner‐La Rocca

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Sex‐related differences in contemporary biomarkers for heart failure: a review

    Sex‐related differences in contemporary biomarkers for heart failure: a review by Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, Rudolf A. de Boer

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis

    Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis by Graeme J. Koelwyn, Joseph Pierre Aboumsallem, Kathryn J. Moore, Rudolf A. de Boer

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Telomere biology in healthy aging and disease

    Telomere biology in healthy aging and disease by Hisko Oeseburg, Rudolf A. de Boer, Wiek H. van Gilst, Pim van der Harst

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin <i>vs</i> placebo or empagliflozin in patients with type 2 diabetes and heart failure

    Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin <i>vs</i> placebo or empagliflozin in patients with type 2 diabetes and heart failure by Rudolf A. de Boer, Julio Núñez, Plamen Kozlovski, Yi Wang, Pieter Proot, Deborah Keefe

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: